[Serum viscosity and chronic hepatopathies]

Area of Science:

• Clinical Medicine
• Biochemistry
• Neurology

Context:

• Chronic liver disease (CLD) affects liver function and can lead to systemic complications.
• Central nervous system (CNS) involvement is a serious manifestation of advanced liver disease, known as hepatic encephalopathy.
• Serum viscosity, a measure of blood's resistance to flow, can be altered in various disease states.

Purpose:

• To investigate the relationship between serum viscosity and central nervous system (CNS) involvement in patients with chronic liver disease.
• To determine if changes in serum viscosity correlate with the presence or severity of neurological symptoms in CLD patients.
• To evaluate the potential role of serum hyperviscosity as a contributing factor to cirrhosis encephalopathy.

Summary:

• Serum viscosity was measured in 26 patients with chronic liver disease.
• Increased serum viscosity was observed in 42% of patients, frequently associated with CNS symptoms.
• Improvement in CNS symptoms correlated with a normalization of serum viscosity levels, suggesting serum hyperviscosity as a potential cause of hepatic encephalopathy.
• Elevated serum viscosity in these patients was primarily linked to increased immunoglobulin levels (IgG, IgA, IgM) rather than total globulins.

Impact:

• Highlights serum hyperviscosity as a potential, underrecognized cause of hepatic encephalopathy in chronic liver disease.
• Suggests monitoring serum viscosity could aid in diagnosing and managing neurological complications in CLD patients.
• Provides evidence for the link between immunoglobulin abnormalities and neurological dysfunction in liver disease.